Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Gyenis L, Duncan JS, Turowec JP, Bretner M, Litchfield DW.

J Proteome Res. 2011 Nov 4;10(11):4887-901. doi: 10.1021/pr2008994. Epub 2011 Oct 13.

2.

Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.

Gyenis L, Turowec JP, Bretner M, Litchfield DW.

Biochim Biophys Acta. 2013 Jul;1834(7):1352-8. doi: 10.1016/j.bbapap.2013.02.006. Epub 2013 Feb 14. Review.

PMID:
23416530
3.

An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.

Duncan JS, Gyenis L, Lenehan J, Bretner M, Graves LM, Haystead TA, Litchfield DW.

Mol Cell Proteomics. 2008 Jun;7(6):1077-88. doi: 10.1074/mcp.M700559-MCP200. Epub 2008 Feb 7.

4.

Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.

Gyenis L, Kuś A, Bretner M, Litchfield DW.

J Proteomics. 2013 Apr 9;81:70-9. doi: 10.1016/j.jprot.2012.09.017. Epub 2012 Sep 25.

PMID:
23017496
5.

Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.

Turowec JP, Duncan JS, French AC, Gyenis L, St Denis NA, Vilk G, Litchfield DW.

Methods Enzymol. 2010;484:471-93. doi: 10.1016/B978-0-12-381298-8.00023-X.

PMID:
21036246
6.

Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.

Franchin C, Cesaro L, Salvi M, Millioni R, Iori E, Cifani P, James P, Arrigoni G, Pinna L.

Biochim Biophys Acta. 2015 Jun;1854(6):609-23. doi: 10.1016/j.bbapap.2014.09.017. Epub 2014 Sep 30.

PMID:
25278378
7.

Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.

Venerando A, Franchin C, Cant N, Cozza G, Pagano MA, Tosoni K, Al-Zahrani A, Arrigoni G, Ford RC, Mehta A, Pinna LA.

PLoS One. 2013 Sep 18;8(9):e74232. doi: 10.1371/journal.pone.0074232. eCollection 2013.

8.

Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.

Zanin S, Sandre M, Cozza G, Ottaviani D, Marin O, Pinna LA, Ruzzene M.

Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1694-707. doi: 10.1016/j.bbapap.2015.04.026. Epub 2015 Apr 30.

PMID:
25936516
9.
10.

Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.

Tapia JC, Bolanos-Garcia VM, Sayed M, Allende CC, Allende JE.

J Cell Biochem. 2004 Apr 1;91(5):865-79.

PMID:
15034923
11.

Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Laudet B, Barette C, Dulery V, Renaudet O, Dumy P, Metz A, Prudent R, Deshiere A, Dideberg O, Filhol O, Cochet C.

Biochem J. 2007 Dec 15;408(3):363-73.

12.

Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Li X, Rao V, Jin J, Guan B, Anderes KL, Bieberich CJ.

J Proteome Res. 2012 Jul 6;11(7):3637-49. doi: 10.1021/pr3000514. Epub 2012 Jun 18.

13.

Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.

Leung KK, Shilton BH.

Biochemistry. 2015 Jan 13;54(1):47-59. doi: 10.1021/bi500959t. Epub 2014 Nov 18.

PMID:
25379648
14.

Casein kinase 2 binds and phosphorylates the nucleosome assembly protein-1 (NAP1) in Drosophila melanogaster.

Li M, Strand D, Krehan A, Pyerin W, Heid H, Neumann B, Mechler BM.

J Mol Biol. 1999 Nov 12;293(5):1067-84.

PMID:
10547286
15.

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA.

J Med Chem. 2004 Dec 2;47(25):6239-47.

PMID:
15566294
16.

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

Di Maira G, Salvi M, Arrigoni G, Marin O, Sarno S, Brustolon F, Pinna LA, Ruzzene M.

Cell Death Differ. 2005 Jun;12(6):668-77.

17.

Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.

Salvi M, Sarno S, Cesaro L, Nakamura H, Pinna LA.

Biochim Biophys Acta. 2009 May;1793(5):847-59. doi: 10.1016/j.bbamcr.2009.01.013. Epub 2009 Jan 31.

18.

Identification and expression pattern of two novel alternative splicing variants of EEF1D gene of dairy cattle.

Xie Y, Yang S, Cui X, Jiang L, Zhang S, Zhang Q, Zhang Y, Sun D.

Gene. 2014 Jan 25;534(2):189-96. doi: 10.1016/j.gene.2013.10.061. Epub 2013 Nov 14.

PMID:
24239553
19.

CK2 phosphorylation of C/EBPδ regulates its transcription factor activity.

Schwind L, Zimmer AD, Götz C, Montenarh M.

Int J Biochem Cell Biol. 2015 Apr;61:81-9. doi: 10.1016/j.biocel.2015.02.004. Epub 2015 Feb 11.

PMID:
25680545
20.

Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.

Chekanov MO, Ostrynska OV, Synyugin AR, Bdzhola VG, Yarmoluk SM.

J Enzyme Inhib Med Chem. 2014 Jun;29(3):338-43. doi: 10.3109/14756366.2013.782024. Epub 2013 Apr 11.

PMID:
23578312

Supplemental Content

Support Center